CD8A and neoplasm: In an orthotopic 4T1 model, FCA-PDT-RT achieved superior tumor control at only 12 Gy, which correlated with increased CD3<sup>+</sup>/CD8<sup>+</sup> T cell infiltration and suppressed angiogenesis, while maintaining favorable safety.